Department of Chemical and Biomolecular Engineering, BK21 Plus Program, KAIST, 291 Daehak-ro Yuseong-gu, Daejeon 34141, Republic of Korea.
Department of Chemical and Biomolecular Engineering, BK21 Plus Program, KAIST, 291 Daehak-ro Yuseong-gu, Daejeon 34141, Republic of Korea; Advanced Biomass R&D Center (ABC), 291 Daehak-ro Yuseong-gu, Daejeon 34141, Republic of Korea.
Bioresour Technol. 2017 Dec;245(Pt B):1386-1392. doi: 10.1016/j.biortech.2017.05.111. Epub 2017 May 20.
The Klebsiella oxytoca was engineered to produce 2,3-butanediol (2,3-BDO) simultaneously utilizing glucose and galactose obtained from a Golenkinia sp. hydrolysate. For efficient uptake of galactose at a high concentration of glucose, Escherichia coli galactose permease (GalP) was introduced, and the expression of galP under a weak-strength promoter resulted in simultaneous consumption of galactose and glucose. Next, to improve the sugar consumption, a gene encoding methylglyoxal synthase (MgsA) known as an inhibitor of multisugar metabolism was deleted, and the mgsA-null mutant showed much faster consumption of both sugars than the wild-type strain did. Finally, we demonstrated that the engineered K. oxytoca could utilize sugar extracts from a Golenkinia sp. hydrolysate and successfully produces 2,3-BDO.
将产酸克雷伯氏菌工程化为能够同时利用来源于戈尔登金氏菌水解物的葡萄糖和半乳糖生产 2,3-丁二醇(2,3-BDO)。为了在高浓度葡萄糖下有效吸收半乳糖,引入了大肠杆菌半乳糖透过酶(GalP),并在弱启动子下表达 galP,导致半乳糖和葡萄糖的同时消耗。接下来,为了提高糖的消耗,删除了编码甲基乙二醛合酶(MgsA)的基因,该基因已知是多聚糖代谢的抑制剂,mgsA 缺失突变体比野生型菌株对半乳糖和葡萄糖的消耗速度更快。最后,我们证明了工程化的产酸克雷伯氏菌可以利用戈尔登金氏菌水解物的糖提取物,并成功生产 2,3-丁二醇。